glp-1 cancer drugs may reduce the risk of progressing, study suggests glp 1 for breast cancer

Nausea and flushing are the most common reactions, often appearing soon after dosing

(PubMed) Selhub J, Bagley LC, Miller J, Rosenberg IH

Conclusions Regarding the controversy of whether GLP-1based therapy can increase the risk for specific malignant disease like pancreatic carcinoma and thyroid cancer, our conclusion is that apparently there is neither firm evidence in favor of this hypothesis nor evidence strong enough to rule out any such increased risk based on results available at present

*NRV/: Nutrient Reference Values (Regulation (EU) No 1169/2011)

Among racial groups, Black faced the highest risk of anxiety, with a 137% elevated risk (HR: 2.37, 95% CI 2.252.50) compared to non-users